Institution statistics

ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL - ALTA SRL - Italy 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:600-700
Total Number of Projects:67
Total Project Funding:700-800
Networking Rank (Reputation):700-800
Networking Rank (Reputation):700-800
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:900-1000
Total Number of Projects:> 1000
Total Project Funding:400-500
Networking Rank (Reputation):900-1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
Total Project Funding:600-700
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 34
As coordinator: 1
As participant: 31
Sole participant: 2
Coordinator / Participant Ratio: 0.03*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 1.035.463 0 1
2018 0 7.437.128 260.600 1
2017 0 13.594.515 465.383 2
2016 0 11.365.807 180.000 3
2015 0 9.404.500 200.000 2
2014 0 5.982.400 150.000 1
2013 0 14.741.378 440.000 3
2012 0 17.897.850 1.089.539 4
2011 0 35.293.677 354.601 3
2010 0 16.360.905 525.200 2
2009 0 1.100.000 157.143 1
2008 0 7.195.960 692.328 2
2007 0 10.231.130 745.903 2
2006 1.936.962 0 380.595 2
2005 0 19.374.586 1.241.690 2
2004 0 6.000.000 272.727 1
2003 0 15.550.000 518.333 1
2002 63.154 0 63.154 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD9
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
CONSIGLIO NAZIONALE DELLE RICERCHE5
INSTITUT PASTEUR5
KING'S COLLEGE LONDON4
UNIVERSITAETSKLINIKUM FREIBURG4
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
FONDAZIONE HUMANITAS PER LA RICERCA3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
ISTITUTO SUPERIORE DI SANITA3
KAROLINSKA INSTITUTE3
UNIVERSITA DEGLI STUDI DI GENOVA3
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
CELLOGIC2
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
DEUTSCHES KREBSFORSCHUNGSZENTRUM2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
FONDAZIONE PER L'ISTITUTO DI RICERC A IN BIOMEDICINA2
FUNDACAO OSWALDO CRUZ2
FUNDACIO INSTITUT CATALA DE NANOCIENCIA I NANOTECNOLOGIA2
GENOME IDENTIFICATION DIAGNOSTICS2
GLAXOSMITHKLINE VACCINES2
HEALTH PROTECTION AGENCY2
HOOKIPA BIOTECH2
HOSPICES CANTONAUX CHUV2
ICON CLINICAL RESEARCH LIMITED2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
KLINIKUM DER UNIVERSITAET REGENSBURG2
LUDWIG INSTITUT FUER KREBSFORSCHUNG2
LUDWIG INSTITUT FUER KREBSFORSCHUNG2
LUNDS UNIVERSITET2
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN2
MILTENYI BIOTEC2
NOVARTIS VACCINES AND DIAGNOSTICS2
PLURISTEM2
SANTARIS PHARMA2
THE UNIVERSITY OF MANCHESTER2
UNIVERSITAET INNSBRUCK2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITE DE GENEVE2
UNIVERSITY COLLEGE LONDON2
UNIVERSITY OF ABERDEEN2
UNIVERSITY OF BIRMINGHAM2
WEIZMANN INSTITUTE OF SCIENCE2
ABERA BIOSCIENCE AB1
ABS INTERNATIONAL1
ACADEMISCH ZIEKENHUIS LEIDEN1
AGENDIA BV1
ALBERT LUDWIGS UNIVERSITAET FREIBURG1
ALERGENETICA SL1
ALFA WASSERMANN1
ALFASIGMA1
AMBIOTIS SAS1
ANAXOMICS BIOTECH S L1
APOINTECH SL1
APPLIED NANOPARTICLES SL1
ARENAVAX1
ASKLEPIOS KLINIKEN HAMBURG1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTELLAS PHARMA EUROPE B V1
ATLAS BIOLABS1
AVANTICELL SCIENCE1
AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO1
BE THE PARTNER1
BE THE PARTNER INC1
BERING LIMITED1
BIOMEDCODE HELLAS1
BIOMEDICAL RESEARCH FOUNDATION ACADEMY OF ATHENS1
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING1
BIONEEDLE TECHNOLOGIES GROUP BV1
BLUSENSE DIAGNOSTICS APS1
BRISTOL MYERS SQUIBB INTERNATIONAL CORPORATION1
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST1
CARDIFF UNIVERSITY1
CENIX BIOSCIENCE1
CENTRE HOSPITALIER UNIVERSITAIRE DE LIEGE1
CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS1
CHINA NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH CO1
CLINIT1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONSORZIO INTERUNIVERSITARIO BIOTECNOLOGIE1
CONSORZIO ITALBIOTEC1
CROSSBETA BIOSCIENCES BV1
DEBIOPHARM1
DEPARTMENT OF HEALTH1
DIAGNOSTICUM GYARTO ES FORGALMAZO ZARTKORUEN MUKODO RESZVENYTARSASAG1
DOMPE FARMACEUTICI1
DOMPE PHA R MA1
DUOTOL AB1
DYNETIX1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ECOAST1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
ELECTRO SCIENTIFIC INDUSTRIES EUROPE1
EMORY UNIVERSITY NON PROFIT CORP1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
Constancy:

Total number of partners:303

Partner loyalty:
Frequent Partner: (> 2 projects): 53
Rare Partner: 250

Frequent / Rare Partner Ratio: 0.21

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES12
RTD HORIZONTAL TOPICS3
SOCIAL AND ECONOMIC CONCERNS1

Project overview:

Start dateProjectacronymrolefundingpartners
2019-01-01Quantitative detection of bacterial endotoxin by novel nanotechnological approaches ENDONANOparticipant1.035.4638
2018-01-01Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial HIPGENparticipant7.437.12811
2017-01-01A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies PACEparticipant7.595.7158
2017-01-01SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS LIVERHOPEparticipant5.998.80018
2016-11-01Improving the flow in the pipeline of the next generation of marine biodiscovery scientists MarPipeparticipant2.853.00514
2016-01-01Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities. HEP-CARparticipant5.698.31010
2016-01-01Probing safety of nano-objects by defining immune responses of environmental organisms PANDORAparticipant2.814.49112
2015-11-01A training network for the rational design of the next generation of well-defined glycoconjugate vaccines GLYCOVAXparticipant3.554.50012
2015-05-01An integrated approach to dissect determinants, risk factors and pathways of ageing of the immune system. ImmunoAgeingparticipant5.850.0004
2014-02-01Biomarker Development for Postoperative Cognitive Impairment in the Elderly BIOCOGparticipant5.982.40012
2013-10-01Human cystic Echinococcosis ReseArch in CentraL and Eastern Societies HERACLESparticipant2.861.50010
2013-09-01Targeting novel lipid pathways for treatment of cardiovascular disease ATHERO-FLUXparticipant5.987.70011
2013-09-01Targeting and exploiting B cell functions for treatment in cardiovascular disease ATHERO-B-CELLparticipant5.892.17811
2012-11-01Personalized minimization of immunosuppression after solid organ transplantation by biomarker-driven stratification of patients to improve long-term outcome and health-economic data of transplantation BIO-DRIMparticipant5.989.00017
2012-11-01"Pathogen COinfection: HIV, Tuberculosis, Malaria and Hepatitis C virus" PATHCOparticipant5.909.69011
2012-01-01Targeting Src-family tyrosine kinases in chronic autoimmune and inflammatory diseases TARKINAIDparticipant2.999.86011
2012-01-01TargetIng novel MEchanisms of Resolution in inflammation TIMERparticipant2.999.30013
2011-10-01Enable the powder metallurgy process to expand to new markets with more reliable parts and lower manufacturing costs through the inspection of green parts DIRA-GREENparticipant2.347.80014
2011-10-01Advanced Immunization Technologies ADITECparticipant29.980.67052
2011-03-01Integrating chemical approaches to treat pancreatic cancer: making new leads for a cure Panacreasparticipant2.965.20712
2010-12-01"Fungi in the setting of inflammation, allergy and autoimmune diseases:Translating basic science into clinical practices" ALLFUNparticipant5.524.70414
2010-11-01A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation THE ONE STUDYparticipant10.836.20116
2009-11-01Development of carbon monoxide releasing molecules for the treatment of rheumatoid arthritis CORMRAparticipant1.100.0007
2008-11-01Set up and comparison of multiple stem cell approaches for kidney repair STAR-T REKparticipant2.999.50011
2008-01-01Design of a vaccine to immunize neonates against GBS infections through a durable maternal immune response DEVANIparticipant4.196.46010
2007-02-01New preventative and therapeutic Hepatits C vaccines: from pre-clinical to phase I HEPACIVACparticipant8.795.00015
2007-01-01Innate immunity in influenza virus infection of mammalian airways FLUINNATEparticipant1.436.1309
2006-09-01Novel opportunities to develop vaccines to control anti-bacterial resistant encapsulated bacteria: from the trials back to the laboratory. The Reverse Clinical Vaccinology approach REBAVACcoordinator121.2001
2006-03-01European Initiative for Basic Research in Microbiology and Infectious Diseases EIMIDcoordinator1.815.7627
2005-11-01Innovative chemokine-based therapeutic strategies for autoimmunity and chronic inflammation INNOCHEMparticipant11.889.09629
2005-06-01Design of small molecule therapeutics for the treatment of Alzheimer's disease on the discovery of innovative drug targets ADITparticipant7.485.4909
2004-06-01Translational and Functional Onco-Genomics: from cancer-oriented genomic screenings to new diagnostic tools and improved cancer treatment. TRANSFOGparticipant6.000.00022
2003-12-01Mucosal Vaccines for Poverty Related Diseases MUVAPREDparticipant15.550.00030
2002-07-01European conference/workshop on "novel strategies of mucosal immunisation through exploitation of mechanisms of innate immunity in pathogen-host interaction" (INNAMORA) INNAMORAcoordinator63.1541

Alias institution names:
  • ALTA LAB
  • ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE
  • ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA
  • ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU
  • ALTA RICERCA E SVILUPPO IN BIOTENOLOGIE

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum